Evra

Evra is a transdermal contraceptive patch containing Ethinylestradiol and Norelgestromin. It is used for birth control and may also help regulate menstrual cycles. This patch is applied weekly for three weeks, followed by a patch-free week.

Evra is primarily used for birth control. It works by releasing hormones through the skin to prevent ovulation and thicken cervical mucus, making it harder for sperm to reach an egg. Some users also find it helpful for managing menstrual irregularities. The patch is designed for transdermal use, applied to the skin once a week for three consecutive weeks, followed by a week without a patch.

Common effects of Evra may include skin irritation at the application site, breast tenderness, headaches, and nausea. Some users report changes in menstrual bleeding patterns, such as lighter or more frequent periods. These effects vary among individuals and typically subside as the body adjusts to the medication.

Evra should be used with caution by individuals with a history of blood clots, high blood pressure, or certain types of cancer. It is important to follow the application instructions carefully to ensure proper adherence and effectiveness. Regular check-ups with a healthcare provider are recommended while using this contraceptive method.

Evra may interact with certain medications, including those that affect liver enzymes, such as some antibiotics and antifungal drugs. It is advisable to consult a healthcare provider before starting or stopping any new medications while using Evra. Additionally, the effectiveness of the patch may be reduced if it becomes loose or falls off.